The DEA Finally Decides To Reschedule Hydrocodone
Posted on August 27, 2014 by Tower MSA Partners
Last week the DEA released a final rule on the rescheduling of hydrocodone removing it from the schedule III controlled substances list in favor of a schedule II designation. To be clear, this decision specifically addresses hydrocodone combination products (i.e.,…
How Will State Boards of Pharmacy Respond to Senate Committee’s Compounding Inquiry?
Posted on December 13, 2012 by Rita Wilson
On November 19th, Chairman Tom Harkin (D-IA), Ranking Member Mike Enzi (R-WY) and members of the Senate Health, Education, Labor and Pensions Committee sent letters to all fifty state boards of pharmacy, the entities responsible for maintaining registries of pharmacies…
Join Us In Vegas… Ask How Tower Triage Can Save Millions
Posted on October 29, 2012 by Tower MSA Partners
Wednesday, Nov 7-9 Las Vegas Convention Center. For 20 years, the National Workers’ Compensation and Disability Conference® & Expo has been the industry’s leading training event. And this year’s event is taking it to the next level – making it…
For Media Inquires, Contact:
Helen King Patterson
813.690.4787
helen@kingknight.com
Search our blog:
Contact Us for a FREE Consultation